Rivera-Flores AG, Mejía-Loza SMI, Pérez LN, Zamarripa-Dorsey F

Language: Spanish
References: 8
Page: 45-48
PDF size: 251.37 Kb.

ABSTRACT

Liver adenoma (LA) is a rare benign neoplasm, localized mainly in the right lobe, 80% solitary, common in women of reproductive age, with prolonged oral contraceptive intake, the main complications are bleeding and its malignant degeneration. We present the case to review current concepts of this entity. Clinical case: 18-year-old male patient, no significant medical history. He is admitted to the emergency department with abdominal pain, and on the physical examination a right upper quadrant abdominal mass. Abdominal ultrasonography (USG) reports: possible hepatic neoplasia in right lobe, corroborated by abdominal tomography. CT-guided liver biopsy was performed resulting in hepatocellular adenoma. It was treated with partial hepatectomy and histopathological study showed a hepatic adenoma subtype beta catenin mutated. Conclusion: Liver adenoma is a recognized entity; therapeutic behavior is based on tumor size and molecular subtype.

REFERENCES

1. Ramia JM, Bernardo C, Valdivieso A, Dopazo C, Jover JM, Albiol MT, et al. Estudio multicéntrico sobre adenomas hepáticos. Ci Esp 2014; 92(2): 120-5.

2. Grazioli L, Ambrosini R, Frittoli B, Grazioli M, Morone M. Primary benign liver lesions. Eur J Radiol 2017; 95: 378-98.

3. Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol 2013; 2013: 604860.

4. Marín-Camero N, Fernández-Aguilar JL, Sánchez-Pérez B, Suárez-Muñoz MA, Santoyo-Santoyo J. De la hiperplasia nodular focal al adenoma inflamatorio hepático. Cir Esp 2012; 90(3): 200-1.

5. Nault JC, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc JF, et al. Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation. Gastroenterology 2017; 152(4): 880-94.e6.

6. Dhingra S, Fiel MI. Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics. Arch Pathol Lab Med 2014; 138(8): 1090-7.

7. Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 2010; 12(8): 509-22.

8. van Aalten SM, Witjes CD, de Man RA, Ijzermans JN, Terkivatan T. Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int 2012; 32(1): 28-37.